Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.2% | +18.0% |
| SALVOZA, M FRANCO G | 1 | 68.7% | +29.6% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 51.7% | +77.8% |
| GRASER, JENNIFER E | 1 | 76.5% | +23.6% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.2% |
| BAUSCH, SARAE L | 1 | 29.6% | +44.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | GRASER, JENNIFER E | 119d overdue |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 4d overdue |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | GRASER, JENNIFER E | 119d overdue |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 4d overdue |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | — |
| 18274565 | REACTIVATION OF EMBRYONIC AND FETAL HEMOGLOBIN | JOHNSON, CHRISTOPHER LINDSAY | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| 1691 | 1 |
| 1645 | 1 |
| 1681 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | — | §102§103§112DP | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 1672 | §103§112 | Final Rejection | 9d | Pending | Oct 25, 2023 |
| 18274565 | REACTIVATION OF EMBRYONIC AND FETAL HEMOGLOBIN | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §112 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | GRASER, JENNIFER E | 1645 | §103§112 | Non-Final OA | 119d overdue | Pending | Jun 22, 2023 |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 1681 | §101§102§112 | Final Rejection | 4d overdue | Pending | Mar 01, 2023 |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Final Rejection | 15d | Pending | Sep 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial